The Epidermal Growth Factor Receptor Modulates the Interaction of E-cadherin with the Actin Cytoskeleton*
- From the Departments of ‡Surgery and ¶Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Abstract
Alterations in the expression or function of molecules that affect cellular adhesion and proliferation are thought to be critical events for tumor progression. Loss of expression of the cell adhesion molecule E-cadherin and increased expression of the epidermal growth factor receptor are two prominent molecular events that are associated with tumorigenesis. The regulation of E-cadherin-dependent cell adhesion by epidermal growth factor (EGF) was therefore examined in the human breast cancer cell line, MDA-MB-468. In this study, changes were observed in the subcellular distribution of components that mediate the cytoplasmic connection between E-cadherin and the actin-based cytoskeleton in response to activation of the EGF receptor. Serum withdrawal activated E-cadherin-dependent cell-cell aggregation in MDA-MB-468 cells, and this treatment stimulated the interaction of actin, α-actinin, and vinculin with E-cadherin complexes, despite the absence of α-catenin in these cells. By contrast, the co-precipitation of actin with E-cadherin was not detected in several α-catenin positive epithelial cell lines. Treatment with EGF inhibited cellular aggregation but did not affect either the levels of E-cadherin or catenin expression nor the association of catenins (β-catenin, plakoglobin/γ-catenin, or p120cas) with E-cadherin. However, EGF treatment of the MDA-MB-468 cell line dissociated actin, α-actinin, and vinculin from the E-cadherin-catenin complex, and this coincided with a robust phosphorylation of β-catenin, plakoglobin/γ-catenin, and p120cas on tyrosine residues. Furthermore, inactivation of the EGF receptor in serum-treated MDA-MB-468 cells with either a function-blocking antibody or EGF receptor kinase inhibitors mimicked the effects of serum starvation by stimulating both cellular aggregation and assembly of E-cadherin complexes with vinculin and actin. These results demonstrate that the EGF receptor directly regulates cell-cell adhesion through modulation of the interaction of E-cadherin with the actin cytoskeleton and thus substantiates the coordinate role of both of these molecules in tumor progression and metastasis.
Footnotes
-
↵* This work was supported by the Department of Surgery at the Memorial Sloan-Kettering Cancer Center and SPORE in breast cancer grant 1P50CA68425 (to L. N.) from the National Cancer Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ To whom correspondence should be addressed: The Derald H. Ruttenberg Cancer Center, Mount Sinai Medical Center, One Gustave Levy Place, Box 1130, New York, NY 10029. Tel.: 212-824-8168; Fax: 212-987-2240; E-mail: rhazan{at}smtplink.mssm.edu.
-
↵1 The abbreviations used are: EGFR, epidermal growth factor receptor; EGF, epidermal growth factor; FBS, fetal bovine serum; BSA, bovine serum albumin; PAGE, polyacrylamide gel electrophoresis; HBSS, Hanks’ balanced saline solution; mAb, monoclonal antibody; DMSO, dimethylsulfoxide.
-
↵2 R. B Hazan, unpublished results.
-
- Received October 20, 1997.
- Revision received January 5, 1998.
- The American Society for Biochemistry and Molecular Biology, Inc.











